Thermo Fisher Scientific | TMO - Net Income

Stock Price
466.76
Daily Change
4.16 0.90%
Monthly
-4.39%
Yearly
14.68%
Q2 Forecast
459.45

Thermo Fisher Scientific reported $1.65B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Bruker USD 26M 88.4M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -146M 281M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Henry Schein USD 107M 6M Mar/2026
Illumina USD 134M 200M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
IQVIA Holdings USD 514M 183M Dec/2025
Laboratory Of America USD 277.8M 113.1M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
Olympus JPY 14.17B 6.03B Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Stryker USD 745M 104M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Veracyte USD 41.15M 22.01M Dec/2025
Waters USD 225.21M 76.29M Dec/2025
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026